Standout Papers

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-de... 2003 2026 2010 2018 628
  1. Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies (2003)
    Jean‐Pierre J. Issa, Guillermo Garcia‐Manero et al. Blood

Immediate Impact

1 by Nobel laureates 22 from Science/Nature 67 standout
Sub-graph 1 of 21

Citing Papers

A signal processing and deep learning framework for methylation detection using Oxford Nanopore sequencing
2024 Standout
Transient loss of Polycomb components induces an epigenetic cancer fate
2024 StandoutNature
1 intermediate paper

Works of Rajan K. Mannari being referenced

Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies
2003 Standout

Author Peers

Author Last Decade Papers Cites
Rajan K. Mannari 687 89 378 3 840
Emel Bayar 608 144 307 8 790
Barbara Adler‐Brecher 458 112 193 9 665
N. Roubi 542 82 366 7 784
Jackie Fiorentino 600 88 470 7 690
Karin B. Gale 376 277 313 8 756
Emily Whisenant 732 159 716 11 984
G. F. Barker 529 344 507 7 888
Carol Wai 639 192 174 5 870
Zhongling Cai 615 114 664 9 958
Jan Davis 429 223 606 7 800

All Works

Loading papers...

Rankless by CCL
2026